E-LIB Suche - Ergebnisse für: Phanuphak, P

1

OA3-5 LB Effect of vorinostat, hydroxychloroquine and marav..:

Kroon, E. ; Ananworanich, J. ; Eubanks, K....
Journal of Virus Eradication. 2 (2016) - p. 5-6 , 2016

Link: https://doi.org/10.1016/..

2

Pharmacokinetic and Pharmacodynamic Comparison of Once‐Dail..:

Dickinson, L ; Amin, J ; Else, L...
Clinical Pharmacology & Therapeutics. 98 (2015) 4 - p. 406-416 , 2015

Link: https://doi.org/10.1002/..

3

APOBEC3G and G-to-A hypermutation in Asian children with di..:

Bunupuradah, T. ; Matsuoka, K. ; Imahashi, M....
International Journal of Infectious Diseases. 21 (2014) - p. 296 , 2014

Link: https://doi.org/10.1016/..

4

Predictors of Clinical Progression in HIV-1-Infected Adults..:

Byakwaga, H. ; Petoumenos, K. ; Ananworanich, J....
Journal of the International Association of Providers of AIDS Care (JIAPAC). 12 (2013) 4 - p. 270-277 , 2013

Link: https://doi.org/10.1177/..

5

Impaired neurocognitive function among HIV‐infected Thais o..:

Avihingsanon, A ; Maek‐a‐nantawat, W ; Sithinamsuwan, P...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

6

Interest in the 'Test and Treat' strategy for HIV preventio..:

Maek‐a‐nantawat, W ; Phanuphak, N ; Teeratakulpisarn, N...
Journal of the International AIDS Society. 15 (2012) S4 - p. 1-1 , 2012

Link: https://doi.org/10.7448/..

7

Determinants of epidermal nerve fibre density in antiretrov..:

Shikuma, CM ; Gerschenson, M ; Ananworanich, J...
HIV Medicine. 13 (2012) 10 - p. 602-608 , 2012

Link: https://doi.org/10.1111/..

8

Cardiovascular risk assessment in persons with HIV infectio..:

Edwards-Jackson, N ; Kerr, SJ ; Tieu, HV...
HIV Medicine. 12 (2011) 8 - p. 510-515 , 2011

Link: https://doi.org/10.1111/..

9

HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive ..:

Sungkanuparph, S. ; Oyomopito, R. ; Sirivichayakul, S....
Clinical Infectious Diseases. 52 (2011) 8 - p. 1053-1057 , 2011

Link: https://doi.org/10.1093/..

10

Prediction of response to antiretroviral therapy by human e..:

Zazzi, M ; Kaiser, R ; Sönnerborg, A...
HIV Medicine. 12 (2010) 4 - p. 211-218 , 2010

Link: https://doi.org/10.1111/..

11

Measures of site resourcing predict virologic suppression, ..:

Oyomopito, R ; Lee, MP ; Phanuphak, P...
HIV Medicine. 11 (2010) 8 - p. 519-529 , 2010

Link: https://doi.org/10.1111/..

12

Cardiovascular risk assessment in persons with HIV in the d..:

Edwards‐Jackson, N ; Kerr, SJ ; Tieu, HV...
Journal of the International AIDS Society. 13 (2010) S4 - p. , 2010

Link: https://doi.org/10.1186/..

13

Deferred modification of antiretroviral regimen following d..:

Zhou, J ; Li, PCK ; Kumarasamy, N...
HIV Medicine. 11 (2009) 1 - p. 31-39 , 2009

Link: https://doi.org/10.1111/..

14

P15-01. Willingness to participate in actual preventive HIV..:

Hemachandra, A ; Puls, RL ; Kerr, SJ...
Retrovirology. 6 (2009) S3 - p. , 2009

Link: https://doi.org/10.1186/..

15

Pharmacokinetics and short-term efficacy of a double-booste..:

van der Lugt, J. ; Autar, R. S. ; Ubolyam, S....
Journal of Antimicrobial Chemotherapy. 61 (2008) 5 - p. 1145-1153 , 2008

Link: https://doi.org/10.1093/..